100 related articles for article (PubMed ID: 26124267)
1. Expression of Apoptotic vs Antiapoptotic Proteins in Middle Ear Cholesteatoma.
Chung JH; Lee SH; Park CW; Kim KR; Tae K; Kang SH; Oh YH; Pyo JY
Otolaryngol Head Neck Surg; 2015 Dec; 153(6):1024-30. PubMed ID: 26124267
[TBL] [Abstract][Full Text] [Related]
2. The oncoprotein, gankyrin, is up-regulated in middle ear cholesteatoma.
Kim KH; Lim HJ; Kim YJ; Kim SW; Kim YS; Tian C; Park K; Park TJ; Choung YH
Acta Otolaryngol; 2014 Mar; 134(3):238-43. PubMed ID: 24460153
[TBL] [Abstract][Full Text] [Related]
3. Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications.
Albino AP; Reed JA; Bogdany JK; Sassoon J; Desloge RB; Parisier SC
Am J Otol; 1998 Jan; 19(1):30-6. PubMed ID: 9455944
[TBL] [Abstract][Full Text] [Related]
4. p53 Expression and keratinocyte hyperproliferation in middle ear cholesteatoma.
Motamed M; Powe D; Kendall C; Birchall JP; Banerjee AR
Clin Otolaryngol Allied Sci; 2002 Dec; 27(6):505-8. PubMed ID: 12472520
[TBL] [Abstract][Full Text] [Related]
5. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
Raynov AM; Moon SK; Choung YH; Hong SP; Park K
Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
[TBL] [Abstract][Full Text] [Related]
6. Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis.
Huisman MA; De Heer E; Grote JJ
Acta Otolaryngol; 2003 Apr; 123(3):377-82. PubMed ID: 12737294
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of Ki-67 expression in recurrent cases of cholesteatoma].
Sanli A; Tezer I; Paksoy M; Aydin S; Hardal U; Ozdemir NB
Kulak Burun Bogaz Ihtis Derg; 2007; 17(2):65-9. PubMed ID: 17527055
[TBL] [Abstract][Full Text] [Related]
8. The role of p21 and p53 proteins in congenital cholesteatoma.
Olszewska E; Rutkowska J; Minovi A; Sieskiewicz A; Rogowski M; Dazert S
Otol Neurotol; 2013 Feb; 34(2):266-74. PubMed ID: 23324739
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
[TBL] [Abstract][Full Text] [Related]
10. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.
Chae SW; Song JJ; Suh HK; Jung HH; Lim HH; Hwang SJ
Laryngoscope; 2000 Nov; 110(11):1898-901. PubMed ID: 11081606
[TBL] [Abstract][Full Text] [Related]
11. [Role of epithelial cell proliferation and apoptosis in human middle ear cholesteatoma].
Zhu W; Huang D; Jing L; Zhang F
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Jul; 15(7):291-2, 295. PubMed ID: 12541781
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of PTEN, P-ERK and P-AKT in the middle ear cholesteatoma].
Liu D; Ma X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Feb; 28(4):238-42, 245. PubMed ID: 24800539
[TBL] [Abstract][Full Text] [Related]
13. Role of Langerhans cells, Ki-67 protein and apoptosis in acquired cholesteatoma: prospective clinical study.
Akdogan V; Yilmaz I; Canpolat T; Ozluoglu LN
J Laryngol Otol; 2013 Mar; 127(3):252-9. PubMed ID: 23331470
[TBL] [Abstract][Full Text] [Related]
14. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.
Shinoda H; Huang CC
Laryngoscope; 1995 Nov; 105(11):1232-7. PubMed ID: 7475882
[TBL] [Abstract][Full Text] [Related]
15. Expression of the p53 and nm23 genes in cholesteatoma.
Bayazit YA; Bakir K; Kanlikama M; Ozer E; Mumbuc S; Disikirik I; Ucak R
Acta Otolaryngol; 2002 Oct; 122(7):726-9. PubMed ID: 12484649
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of epithelial proliferation and apoptosis in cholesteatoma of adults].
Olszewska E; Chodynicki S; Chyczewski L
Otolaryngol Pol; 2003; 57(1):85-9. PubMed ID: 12741150
[TBL] [Abstract][Full Text] [Related]
17. Expression patterns of Ki-67 and telomerase activity in middle ear cholesteatoma.
Kuczkowski J; Pawelczyk T; Bakowska A; Narozny W; Mikaszewski B
Otol Neurotol; 2007 Feb; 28(2):204-7. PubMed ID: 17255888
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of p63 and survivin in cholesteatomas.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the expression of E-cadherin, β-catenin, and β1 integrin in congenital and acquired cholesteatoma.
Lee DW; Chung JH; Lee SH; Park CW; Kang SH; Oh YH; Pyo JY
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):845-51. PubMed ID: 25864182
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of epithelial proliferation in paediatric and adult cholesteatomas using the Ki-67 proliferation marker.
Sikka K; Sharma SC; Thakar A; Dattagupta S
J Laryngol Otol; 2012 May; 126(5):460-3. PubMed ID: 22166746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]